Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 160

Results For "Director"

2341 News Found

Lockwood acquires medical animation studio ‘Random42’ from Graphite Capital
News | June 03, 2022

Lockwood acquires medical animation studio ‘Random42’ from Graphite Capital

The partnership between Lockwood and Random42 expands the capabilities and geographic footprint for both organizations.


How would AI change manufacturing & packaging processes?
News | June 03, 2022

How would AI change manufacturing & packaging processes?

These and many other questions gather worldwide experts of the pharmaceutical industry at the PHARMAP 2022 which takes place in Berlin, Germany on June, 20 - 21, 2022


Vial to launch oncology CRO, Arati Rao named as First Advisor
News | June 02, 2022

Vial to launch oncology CRO, Arati Rao named as First Advisor

The new Oncology CRO will aim to drive faster execution and higher quality trial outcomes for Oncology sponsors.


Digitalization of pharma labs will help in better decision making: Experts
Digitisation | June 02, 2022

Digitalization of pharma labs will help in better decision making: Experts

Besides enhancing workflow operations by connecting scientists with their lab instruments and data, digitalization holds the potential to acceleratee long-term business growth


BGS Gleneagles launches its refurbished advanced emergency & trauma center
Healthcare | June 02, 2022

BGS Gleneagles launches its refurbished advanced emergency & trauma center

120+ members of multi-disciplinary medical team are trained to provide seamless, outcome driven trauma and emergency care


DuPont opens new biopharma tubing manufacturing site in US
News | June 02, 2022

DuPont opens new biopharma tubing manufacturing site in US

The site, located in Berkeley County, will be operated using the same quality standards as DuPont’s Healthcare Industries Materials Site, the company’s longstanding biopharmaceutical manufacturing site in Hemlock, Michigan


ENTOD Pharmaceuticals gets DCGI nod to carry out the phase 3 trials of 0.05% atropine eye drops
Drug Approval | June 01, 2022

ENTOD Pharmaceuticals gets DCGI nod to carry out the phase 3 trials of 0.05% atropine eye drops

Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children


FDA approves Roche’s Evrysdi for use in babies under two months with SMA
Drug Approval | June 01, 2022

FDA approves Roche’s Evrysdi for use in babies under two months with SMA

Evrysdi has proven efficacy in babies, children and adults with more than 5,000 patients treated to date


Tetra Bio-Pharma appoints CFO
People | June 01, 2022

Tetra Bio-Pharma appoints CFO

Auld is a seasoned Financial Executive with over 30 years of relevant experience


Thyrocare unveils new brand identity
News | June 01, 2022

Thyrocare unveils new brand identity

New logo reflects Thyrocare’s transformation since 1996 to its current leading position at the cutting edge of Diagnostic services